nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—Completed suicide—Lamivudine—hepatitis B	0.0234	0.0234	CcSEcCtD
Roflumilast—Respiratory tract infection—Lamivudine—hepatitis B	0.0219	0.0219	CcSEcCtD
Roflumilast—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.0165	0.0165	CcSEcCtD
Roflumilast—Hepatobiliary disease—Entecavir—hepatitis B	0.0157	0.0157	CcSEcCtD
Roflumilast—Gastritis—Telbivudine—hepatitis B	0.0157	0.0157	CcSEcCtD
Roflumilast—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.0154	0.0154	CcSEcCtD
Roflumilast—Influenza—Telbivudine—hepatitis B	0.0153	0.0153	CcSEcCtD
Roflumilast—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.0152	0.0152	CcSEcCtD
Roflumilast—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0143	0.0143	CcSEcCtD
Roflumilast—Immune system disorder—Entecavir—hepatitis B	0.0135	0.0135	CcSEcCtD
Roflumilast—Mental disorder—Entecavir—hepatitis B	0.0131	0.0131	CcSEcCtD
Roflumilast—Malnutrition—Entecavir—hepatitis B	0.013	0.013	CcSEcCtD
Roflumilast—Hepatobiliary disease—Telbivudine—hepatitis B	0.0129	0.0129	CcSEcCtD
Roflumilast—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.0127	0.0127	CcSEcCtD
Roflumilast—Gynaecomastia—Lamivudine—hepatitis B	0.0123	0.0123	CcSEcCtD
Roflumilast—Back pain—Adefovir Dipivoxil—hepatitis B	0.0123	0.0123	CcSEcCtD
Roflumilast—Connective tissue disorder—Telbivudine—hepatitis B	0.0121	0.0121	CcSEcCtD
Roflumilast—Mediastinal disorder—Telbivudine—hepatitis B	0.0111	0.0111	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.011	0.011	CcSEcCtD
Roflumilast—Myalgia—Adefovir Dipivoxil—hepatitis B	0.0108	0.0108	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.0107	0.0107	CcSEcCtD
Roflumilast—Malnutrition—Telbivudine—hepatitis B	0.0107	0.0107	CcSEcCtD
Roflumilast—Infection—Entecavir—hepatitis B	0.0105	0.0105	CcSEcCtD
Roflumilast—Dysgeusia—Telbivudine—hepatitis B	0.0105	0.0105	CcSEcCtD
Roflumilast—Nervous system disorder—Entecavir—hepatitis B	0.0104	0.0104	CcSEcCtD
Roflumilast—Back pain—Telbivudine—hepatitis B	0.0103	0.0103	CcSEcCtD
Roflumilast—Skin disorder—Entecavir—hepatitis B	0.0103	0.0103	CcSEcCtD
Roflumilast—Muscle spasms—Telbivudine—hepatitis B	0.0103	0.0103	CcSEcCtD
Roflumilast—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.0102	0.0102	CcSEcCtD
Roflumilast—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.0101	0.0101	CcSEcCtD
Roflumilast—Ill-defined disorder—Telbivudine—hepatitis B	0.00991	0.00991	CcSEcCtD
Roflumilast—Malaise—Telbivudine—hepatitis B	0.00963	0.00963	CcSEcCtD
Roflumilast—Insomnia—Entecavir—hepatitis B	0.0096	0.0096	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00943	0.00943	CcSEcCtD
Roflumilast—Dyspepsia—Entecavir—hepatitis B	0.00934	0.00934	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Entecavir—hepatitis B	0.00916	0.00916	CcSEcCtD
Roflumilast—Fatigue—Entecavir—hepatitis B	0.00915	0.00915	CcSEcCtD
Roflumilast—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00912	0.00912	CcSEcCtD
Roflumilast—Myalgia—Telbivudine—hepatitis B	0.0091	0.0091	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00903	0.00903	CcSEcCtD
Roflumilast—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.009	0.009	CcSEcCtD
Roflumilast—Discomfort—Telbivudine—hepatitis B	0.00899	0.00899	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00894	0.00894	CcSEcCtD
Roflumilast—Gastrointestinal pain—Entecavir—hepatitis B	0.00868	0.00868	CcSEcCtD
Roflumilast—Influenza—Lamivudine—hepatitis B	0.00864	0.00864	CcSEcCtD
Roflumilast—Nervous system disorder—Telbivudine—hepatitis B	0.00855	0.00855	CcSEcCtD
Roflumilast—Skin disorder—Telbivudine—hepatitis B	0.00847	0.00847	CcSEcCtD
Roflumilast—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00847	0.00847	CcSEcCtD
Roflumilast—Abdominal pain—Entecavir—hepatitis B	0.00839	0.00839	CcSEcCtD
Roflumilast—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00819	0.00819	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00794	0.00794	CcSEcCtD
Roflumilast—Insomnia—Telbivudine—hepatitis B	0.00789	0.00789	CcSEcCtD
Roflumilast—Depression—Lamivudine—hepatitis B	0.00768	0.00768	CcSEcCtD
Roflumilast—Dyspepsia—Telbivudine—hepatitis B	0.00768	0.00768	CcSEcCtD
Roflumilast—Asthenia—Entecavir—hepatitis B	0.00762	0.00762	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00753	0.00753	CcSEcCtD
Roflumilast—Fatigue—Telbivudine—hepatitis B	0.00752	0.00752	CcSEcCtD
Roflumilast—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00743	0.00743	CcSEcCtD
Roflumilast—Hepatobiliary disease—Lamivudine—hepatitis B	0.00729	0.00729	CcSEcCtD
Roflumilast—Diarrhoea—Entecavir—hepatitis B	0.00726	0.00726	CcSEcCtD
Roflumilast—Sinusitis—Lamivudine—hepatitis B	0.00723	0.00723	CcSEcCtD
Roflumilast—Feeling abnormal—Telbivudine—hepatitis B	0.00718	0.00718	CcSEcCtD
Roflumilast—Gastrointestinal pain—Telbivudine—hepatitis B	0.00713	0.00713	CcSEcCtD
Roflumilast—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00709	0.00709	CcSEcCtD
Roflumilast—Dizziness—Entecavir—hepatitis B	0.00702	0.00702	CcSEcCtD
Roflumilast—Rhinitis—Lamivudine—hepatitis B	0.00693	0.00693	CcSEcCtD
Roflumilast—Abdominal pain—Telbivudine—hepatitis B	0.00689	0.00689	CcSEcCtD
Roflumilast—Connective tissue disorder—Lamivudine—hepatitis B	0.0068	0.0068	CcSEcCtD
Roflumilast—Vomiting—Entecavir—hepatitis B	0.00675	0.00675	CcSEcCtD
Roflumilast—Rash—Entecavir—hepatitis B	0.00669	0.00669	CcSEcCtD
Roflumilast—Dermatitis—Entecavir—hepatitis B	0.00669	0.00669	CcSEcCtD
Roflumilast—Headache—Entecavir—hepatitis B	0.00665	0.00665	CcSEcCtD
Roflumilast—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00658	0.00658	CcSEcCtD
Roflumilast—Rash—Adefovir Dipivoxil—hepatitis B	0.00653	0.00653	CcSEcCtD
Roflumilast—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00652	0.00652	CcSEcCtD
Roflumilast—Headache—Adefovir Dipivoxil—hepatitis B	0.00649	0.00649	CcSEcCtD
Roflumilast—Nausea—Entecavir—hepatitis B	0.0063	0.0063	CcSEcCtD
Roflumilast—Asthenia—Telbivudine—hepatitis B	0.00626	0.00626	CcSEcCtD
Roflumilast—Immune system disorder—Lamivudine—hepatitis B	0.00625	0.00625	CcSEcCtD
Roflumilast—Mediastinal disorder—Lamivudine—hepatitis B	0.00623	0.00623	CcSEcCtD
Roflumilast—Nausea—Adefovir Dipivoxil—hepatitis B	0.00615	0.00615	CcSEcCtD
Roflumilast—Malnutrition—Lamivudine—hepatitis B	0.00602	0.00602	CcSEcCtD
Roflumilast—Diarrhoea—Telbivudine—hepatitis B	0.00597	0.00597	CcSEcCtD
Roflumilast—Tension—Lamivudine—hepatitis B	0.00591	0.00591	CcSEcCtD
Roflumilast—Dysgeusia—Lamivudine—hepatitis B	0.0059	0.0059	CcSEcCtD
Roflumilast—Nervousness—Lamivudine—hepatitis B	0.00585	0.00585	CcSEcCtD
Roflumilast—Back pain—Lamivudine—hepatitis B	0.00582	0.00582	CcSEcCtD
Roflumilast—Muscle spasms—Lamivudine—hepatitis B	0.00579	0.00579	CcSEcCtD
Roflumilast—Dizziness—Telbivudine—hepatitis B	0.00577	0.00577	CcSEcCtD
Roflumilast—Tremor—Lamivudine—hepatitis B	0.00564	0.00564	CcSEcCtD
Roflumilast—Ill-defined disorder—Lamivudine—hepatitis B	0.00559	0.00559	CcSEcCtD
Roflumilast—Vomiting—Telbivudine—hepatitis B	0.00554	0.00554	CcSEcCtD
Roflumilast—Angioedema—Lamivudine—hepatitis B	0.0055	0.0055	CcSEcCtD
Roflumilast—Rash—Telbivudine—hepatitis B	0.0055	0.0055	CcSEcCtD
Roflumilast—Dermatitis—Telbivudine—hepatitis B	0.00549	0.00549	CcSEcCtD
Roflumilast—Headache—Telbivudine—hepatitis B	0.00546	0.00546	CcSEcCtD
Roflumilast—Malaise—Lamivudine—hepatitis B	0.00543	0.00543	CcSEcCtD
Roflumilast—Vertigo—Lamivudine—hepatitis B	0.00541	0.00541	CcSEcCtD
Roflumilast—Nausea—Telbivudine—hepatitis B	0.00518	0.00518	CcSEcCtD
Roflumilast—Myalgia—Lamivudine—hepatitis B	0.00513	0.00513	CcSEcCtD
Roflumilast—Anxiety—Lamivudine—hepatitis B	0.00511	0.00511	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00509	0.00509	CcSEcCtD
Roflumilast—Discomfort—Lamivudine—hepatitis B	0.00506	0.00506	CcSEcCtD
Roflumilast—Infection—Lamivudine—hepatitis B	0.00488	0.00488	CcSEcCtD
Roflumilast—Nervous system disorder—Lamivudine—hepatitis B	0.00482	0.00482	CcSEcCtD
Roflumilast—Skin disorder—Lamivudine—hepatitis B	0.00477	0.00477	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00448	0.00448	CcSEcCtD
Roflumilast—Insomnia—Lamivudine—hepatitis B	0.00444	0.00444	CcSEcCtD
Roflumilast—Dyspepsia—Lamivudine—hepatitis B	0.00433	0.00433	CcSEcCtD
Roflumilast—Decreased appetite—Lamivudine—hepatitis B	0.00427	0.00427	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00424	0.00424	CcSEcCtD
Roflumilast—Fatigue—Lamivudine—hepatitis B	0.00424	0.00424	CcSEcCtD
Roflumilast—Constipation—Lamivudine—hepatitis B	0.0042	0.0042	CcSEcCtD
Roflumilast—Feeling abnormal—Lamivudine—hepatitis B	0.00405	0.00405	CcSEcCtD
Roflumilast—Gastrointestinal pain—Lamivudine—hepatitis B	0.00402	0.00402	CcSEcCtD
Roflumilast—Urticaria—Lamivudine—hepatitis B	0.0039	0.0039	CcSEcCtD
Roflumilast—Abdominal pain—Lamivudine—hepatitis B	0.00388	0.00388	CcSEcCtD
Roflumilast—Hypersensitivity—Lamivudine—hepatitis B	0.00362	0.00362	CcSEcCtD
Roflumilast—Asthenia—Lamivudine—hepatitis B	0.00353	0.00353	CcSEcCtD
Roflumilast—Diarrhoea—Lamivudine—hepatitis B	0.00336	0.00336	CcSEcCtD
Roflumilast—Dizziness—Lamivudine—hepatitis B	0.00325	0.00325	CcSEcCtD
Roflumilast—Vomiting—Lamivudine—hepatitis B	0.00312	0.00312	CcSEcCtD
Roflumilast—Rash—Lamivudine—hepatitis B	0.0031	0.0031	CcSEcCtD
Roflumilast—Dermatitis—Lamivudine—hepatitis B	0.0031	0.0031	CcSEcCtD
Roflumilast—Headache—Lamivudine—hepatitis B	0.00308	0.00308	CcSEcCtD
Roflumilast—Nausea—Lamivudine—hepatitis B	0.00292	0.00292	CcSEcCtD
